Orthofix Medical Inc. OFIX NASDAQ

Orthofix Medical Inc. (OFIX) generated $28.48M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $10.87M, free cash flow was $17.61M.

Free cash flow margin was 8% of revenue. Cash conversion ratio was -0.24x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (49/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (10/100) — Cash conversion ratio was -0.24x suggests some earnings are non-cash items

Overall SharesGrow Score: 46/100 with 1/7 criteria passed.